NCT07213622

Brief Summary

The use of smart glasses for saphenous nerve adductor canal blocks compared to standard of care.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2024

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

October 2, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 9, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

October 9, 2025

Status Verified

October 1, 2025

Enrollment Period

1.8 years

First QC Date

October 2, 2025

Last Update Submit

October 2, 2025

Conditions

Total Knee Arthroplasty

Keywords

Total knee arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Time from needle insertion to complete local anesthetic injection

    Until the end of the study

Secondary Outcomes (1)

  • Number of needle adjustments by user, ergonomics, head adjustments

    until the end of the study

Study Arms (2)

Smartglasses

EXPERIMENTAL
Procedure: Smartglasses

Standard of care

NO INTERVENTION

Interventions

SmartglassesPROCEDURE

Wearing smart glasses while performing a nerve block

Smartglasses

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients 18 years or greater
  • undergoing total knee arthroplasty

You may not qualify if:

  • Patients with local infection at nerve block site
  • BMI \>40
  • Patients who are at risk for local anesthesia systemic toxicity due to intraoperative local dose
  • Patients with nerve damage to the femoral or saphenous nerve
  • Documented history of mental or cognitive disabilities in EMR
  • Non-English speaking patient
  • Pregnant Women (self-reported)
  • Prisoners
  • Patients under the age of 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MetroHealth Hospital

Cleveland, Ohio, 44109, United States

Location

MeSH Terms

Interventions

Smart Glasses

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Anesthesiolgist

Study Record Dates

First Submitted

October 2, 2025

First Posted

October 9, 2025

Study Start

March 4, 2024

Primary Completion

December 31, 2025

Study Completion

February 1, 2026

Last Updated

October 9, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations

US(1)